Epsilon Healthcare (ASX:EPN) - Hisse Senedi Fiyatı, Haberler ve Analizler

EPN Stoklara Genel Bakış

Epsilon Healthcare Limited operates as a healthcare and pharmaceuticals company primarily in Australia and Canada. Daha fazla detay

EPN temel anali̇z
Kar Tanesi Skoru
Değerleme	2/6
Gelecekteki Büyüme	0/6
Geçmiş Performans	0/6
Finansal Sağlık	2/6
Temettüler	0/6

Risk Analizi

Kazançlar son 5 yılda yılda 4.2% oranında azaldı

Anlamlı bir piyasa değeri yok ( A$7M )

Hisse senetleri oldukça likit değildir

1 yıldan az nakit akışı var

+ 1 daha fazla risk

Epsilon Healthcare Limited Rakipler

Cann Global

ASX:CGB

AU$5.4m

Avecho Biotechnology

ASX:AVE

AU$6.3m

Ecofibre

ASX:EOF

AU$15.4m

Emyria

ASX:EMD

AU$16.2m

Fiyat Geçmişi ve Performans

için tüm zamanların en yüksek seviyelerinin, değişikliklerin ve fiyat düşüşlerinin özeti Epsilon Healthcare
Tarihsel hisse senedi fiyatları
Güncel Hisse Fiyatı	AU$0.024
52 Haftanın En Yüksek Seviyesi	AU$0.034
52 Haftanın En Düşük Seviyesi	AU$0.016
Beta	0.92
11 Aylık Değişim	0%
3 Aylık Değişim	0%
1 Yıllık Değişim	20.00%
33 Yıllık Değişim	-89.57%
5 Yıllık Değişim	-95.60%
Halka arzdan bu yana değişim	-94.07%

Son Haberler & Güncellemeler

Recent updates

Hissedar Getirileri

	EPN	AU Pharmaceuticals	AU Pazar
7D	0%	-16.4%	0.9%
1Y	20.0%	32.3%	18.4%

Getiri vs. Endüstri: EPN geçen yıl % 32.3 oranında getiri sağlayan Australian Pharmaceuticals sektörünün gerisinde kaldı.

Getiri vs Piyasa: EPN geçen yıl % 18.4 oranında getiri sağlayan Australian Piyasasını aştı.

Fiyat Oynaklığı

Is EPN's price volatile compared to industry and market?
EPN volatility
EPN Average Weekly Movement	n/a
Pharmaceuticals Industry Average Movement	11.9%
Market Average Movement	8.5%
10% most volatile stocks in AU Market	17.5%
10% least volatile stocks in AU Market	3.2%

İstikrarlı Hisse Senedi Fiyatı: EPN son 3 ayda önemli bir fiyat oynaklığı yaşamadı.

Zaman İçindeki Volatilite: EPN 'un son bir yıldaki oynaklık değişimini belirlemek için Yetersiz veri.

Şirket Hakkında

Kuruldu	Çalışanlar	CEO	Web sitesi
2016	n/a	Daniel Sanghera	epsilonhealthcare.com.au

Epsilon Healthcare Limited Temel Bilgiler Özeti

Epsilon Healthcare'un kazançları ve gelirleri piyasa değeriyle nasıl karşılaştırılır?
EPN temel i̇stati̇sti̇kler
Piyasa değeri	AU$7.21m
Kazançlar(TTM)	-AU$5.93m
Gelir(TTM)	AU$7.21m

1.0x

P/S Oranı

-1.2x

F/K Oranı

EPN aşırı değerli mi?

Gerçeğe Uygun Değer ve değerleme analizine bakınız

Kazanç ve Gelir

En son kazanç raporundan temel karlılık istatistikleri (TTM)
EPN gelir tablosu (TTM)
Gelir	AU$7.21m
Gelir Maliyeti	AU$5.09m
Brüt Kâr	AU$2.12m
Diğer Giderler	AU$8.05m
Kazançlar	-AU$5.93m

Son Raporlanan Kazançlar

Jun 30, 2023

Sonraki Kazanç Tarihi

n/a

Hisse başına kazanç (EPS)	-0.02
Brüt Marj	29.46%
Net Kâr Marjı	-82.17%
Borç/Özkaynak Oranı	27.1%

EPN uzun vadede nasıl bir performans gösterdi?

Geçmiş performansı ve karşılaştırmayı görün

EPN Stoklara Genel Bakış

Risk Analizi

Epsilon Healthcare Limited Rakipler

ASX:CGB

AU$5.4m

ASX:AVE

AU$6.3m

ASX:EOF

AU$15.4m

ASX:EMD

AU$16.2m

Fiyat Geçmişi ve Performans

Son Haberler & Güncellemeler

Epsilon Healthcare Appoints Richard Legge as Company Secretary

Epsilon Healthcare Limited Announces Termination of Xiao (Josh) Cui as Company Secretary

Epsilon Healthcare Receive Notice from Watercrest Asset Management Pty Ltd

Epsilon Healthcare Receive Notice from Watercrest Asset Management Pty Ltd

Epsilon Healthcare Limited Announces Board Appointments

Epsilon Healthcare Limited Announces Terminates Peter Giannopoulos as Chief Executive Officer

Recent updates

Epsilon Healthcare Appoints Richard Legge as Company Secretary

Epsilon Healthcare Limited Announces Termination of Xiao (Josh) Cui as Company Secretary

Epsilon Healthcare Receive Notice from Watercrest Asset Management Pty Ltd

Epsilon Healthcare Receive Notice from Watercrest Asset Management Pty Ltd

Epsilon Healthcare Limited Announces Board Appointments

Epsilon Healthcare Limited Announces Terminates Peter Giannopoulos as Chief Executive Officer

Does Epsilon Healthcare (ASX:EPN) Have A Healthy Balance Sheet?

Non-Executive Deputy Chairman recently bought AU$67k worth of stock

First half 2023 earnings released: AU$0.002 loss per share (vs AU$0.035 loss in 1H 2022)

Non-Executive Deputy Chairman recently bought AU$55k worth of stock

Is Epsilon Healthcare (ASX:EPN) Using Too Much Debt?

New minor risk - Share price stability

Epsilon Healthcare Appoints Peter Giannopoulos as Chief Executive Officer, Effective 23 May, 2023

Full year 2022 earnings released: AU$0.066 loss per share (vs AU$0.048 loss in FY 2021)

Epsilon Healthcare Limited Announces Executive Changes

Epsilon Healthcare Limited Appoints Mark Audet as Chief Financial Officer

No independent directors

Epsilon Healthcare Limited Announces Resignation of Simon Rowe as Director

Epsilon Healthcare Limited Announces Board Changes

Epsilon Healthcare Limited Announces Resignation of Nicholas Marshall as Chief Financial Officer

Epsilon Healthcare Limited Announces Executive Changes

First half 2022 earnings released: AU$0.035 loss per share (vs AU$0.022 loss in 1H 2021)

Epsilon Healthcare Limited Announces Resignation of Dr. Rob Jenny as A Director

Epsilon Healthcare Limited Announces Resignation of Jarrod White as Chief Executive Officer

Epsilon Healthcare Limited Appoints Patrick Baiyu Xu as Director

Epsilon Healthcare Limited, Annual General Meeting, May 31, 2022

Epsilon Healthcare Limited announced that it expects to receive AUD 2.1 million in funding

No independent directors

Full year 2021 earnings released: AU$0.046 loss per share (vs AU$0.066 loss in FY 2020)

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Epsilon Healthcare Limited announced that it expects to receive AUD 2.898 million in funding from CPS Capital

First half 2021 earnings released: AU$0.022 loss per share (vs AU$0.039 loss in 1H 2020)

We Think Epsilon Healthcare (ASX:EPN) Has A Fair Chunk Of Debt

Epsilon Healthcare Limited (ASX:EPN) entered into binding heads of agreement to acquire AlternaMed Pty Ltd. from Cannvalate PTY LTD for AUD 4.3 million.

First half 2021 earnings released: AU$0.022 loss per share (vs AU$0.039 loss in 1H 2020)

Joint Company Secretary Philip Leighfield has left the company

Is Epsilon Healthcare (ASX:EPN) Weighed On By Its Debt Load?

Tetra Health Partners with Astrid Healthcare to Operates the Astrid Dispensary in South Yarra

Non Executive Director has left the company

Epsilon Healthcare Limited Announces Resignation of Gary Radcliff as Non-Executive Director

Is Epsilon Healthcare (ASX:EPN) Using Too Much Debt?

Full year 2020 earnings released: AU$0.069 loss per share (vs AU$0.088 loss in FY 2019)

THC Global Group Limited announced that it expects to receive AUD 2.75 million in funding

New 90-day high: AU$0.29

THC Global Group Limited Announces CEO Changes

First half earnings released

New 90-day low - AU$0.24

New 90-day low - AU$0.26

THC Global Group Limited (ASX:THC) completed the acqusition of Tetra Pty Ltd from Meta Growth Corp. (TSXV:META) and others.

New 90-day low - AU$0.27

THC Global Group Limited has completed a Follow-on Equity Offering in the amount of AUD 1.535 million.

Hissedar Getirileri

Fiyat Oynaklığı

Şirket Hakkında

Epsilon Healthcare Limited Temel Bilgiler Özeti

1.0x

-1.2x

Kazanç ve Gelir